Rating History for AN2 Therapeutics (ANTX) by Evercore ISI
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/9/2024 | Liisa Bayko | Downgrade | Underperform (In Line) |
2.00 (N/A) |
2.64 (2.85) |
7.95% | Details |
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/9/2024 | Liisa Bayko | Downgrade | Underperform (In Line) |
2.00 (N/A) |
2.64 (2.85) |
7.95% | Details |
![]() |
|||||||
![]() |
|||||||